• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Talphera reduces NEPHRO CRRT study size to 70 patients

    PR NEWSWIRE

    Talphera Announces 2024 Financial Results and Corporate Update

    PR NEWSWIRE

    Talphera to Host Q4 2024 Financial Results Call on March 31, 2025

    PR NEWSWIRE

    Talphera, FDA Agree to Adjust NEPHRO CRRT Study Patient Numbers

    PR NEWSWIRE

    Talphera to Host Q3 2024 Results Call & Corporate Update

    PR NEWSWIRE

    Talphera To Participate In Fireside Chat At 2024 Maxim Summit

    PR NEWSWIRE

    Talphera Enrolls First Patient In Nafamostat Anticoagulation Trial

    PR NEWSWIRE

    Talphera to Participate at A.G.P. Virtual Healthcare Conference

    PR NEWSWIRE

    Talphera Announces Fourth Quarter 2023 Financial Results

    PR NEWSWIRE

    Talphera Announces Reduction in Size of its Board of Directors

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.